BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8760000)

  • 1. [Primary cerebral non-Hodgkin's lymphoma. Intensive chemotherapy supported by crania radiotherapy].
    Jensen MK; Skejø HP; Jensen MK
    Ugeskr Laeger; 1996 Jul; 158(31):4413-5. PubMed ID: 8760000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful chemotherapy in a primary cerebral centroblastic non-Hodgkin's lymphoma in childhood].
    Baumgarten E; Buchmann S; Fengler R; Grosch-Wörner I; Schulte-Overberg U; Henze G
    Onkologie; 1986 Dec; 9(6):290-4. PubMed ID: 3547222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
    O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary non-Hodgkin's lymphoma of the central nervous system: phase II study of chemotherapy (BVAM) prior to radiotherapy.
    Bessell EM; Punt J; Firth J; Hope T; Holland I; Lowe J
    Clin Oncol (R Coll Radiol); 1991 Jul; 3(4):193-8. PubMed ID: 1718398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.
    Singhal D; Witham TF; Germanwala A; Flickinger JC; Schiff D; Kondziolka D
    Can J Neurol Sci; 2002 May; 29(2):147-53. PubMed ID: 12035835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy of primary cerebral lymphoma].
    Delwail V; Bataille B
    Neurochirurgie; 1997; 43(6):380-4. PubMed ID: 9706617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.
    DeAngelis LM; Seiferheld W; Schold SC; Fisher B; Schultz CJ;
    J Clin Oncol; 2002 Dec; 20(24):4643-8. PubMed ID: 12488408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide, etoposide, cytarabine, and methotrexate as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma.
    Stamatoullas A; Fruchart C; Bastit D; Boulet D; Moncondult M; Piguet H; Tilly H
    Cancer; 1996 Jun; 77(11):2302-7. PubMed ID: 8635099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.
    Calderoni A; Aebi S
    J Neurooncol; 2002 Sep; 59(3):227-30. PubMed ID: 12241119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive treatment of stage III-IV aggressive malignant lymphomas (protocol TPL-84).
    Colombat P; Guilhot F; Bordesoule D; Renou P; Benz-Lemoine E; Fouillard L; Drouet M; Tanzer J; Lamagnere JP
    Haematologica; 1991; 76(6):479-84. PubMed ID: 1726492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.
    Dabaja BS; McLaughlin P; Ha CS; Pro B; Meyers CA; Seabrooke LF; Wilder RB; Kyritsis AP; Preti HA; Yung WK; Levin V; Cabanillas F; Cox JD
    Cancer; 2003 Sep; 98(5):1021-8. PubMed ID: 12942571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series.
    Blay JY; Conroy T; Chevreau C; Thyss A; Quesnel N; Eghbali H; Bouabdallah R; Coiffier B; Wagner JP; Le Mevel A; Dramais-Marcel D; Baumelou E; Chauvin F; Biron P
    J Clin Oncol; 1998 Mar; 16(3):864-71. PubMed ID: 9508167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary non-Hodgkin's lymphomas of the central nervous system. Still more questions than answers in the treatment?].
    Hansen PB; Jensen MK
    Ugeskr Laeger; 2007 Jun; 169(23):2187-9. PubMed ID: 17592682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
    Abrey LE; Moskowitz CH; Mason WP; Crump M; Stewart D; Forsyth P; Paleologos N; Correa DD; Anderson ND; Caron D; Zelenetz A; Nimer SD; DeAngelis LM
    J Clin Oncol; 2003 Nov; 21(22):4151-6. PubMed ID: 14615443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and prognosis of nervous system lesions in lymphosarcoma].
    Kruglova GV; Abdyldaev RA; Finogenova IA; Tarasiuk SV
    Ter Arkh; 1983; 55(8):36-40. PubMed ID: 6688888
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol].
    Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M
    Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.